Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinopathies

Post Date

April 4th 2014

Application Due Date

May 12th 2014

Dates: 1. Letter of Intent (LOI) Deadline: April 25, 2014, 11:59 p.m. U.S. Eastern Standard Time 2. Application Deadline: May 12, 2014, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov 3. Informational conference call for potenti

Funding Opportunity Number

CDC-RFA-DD14-1406

CFDA Number(s)

93.184

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

A. Eligibility Information 1. Eligible Applicants: Government Organizations: ╔ State or their bona fide agents (includes the District of Columbia) ╔ Local governments or their bona fide agents ╔ Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau ╔ State controlled institutions of higher education ╔ American Indian or Alaska Native tribal governments (federally recognized or state-recognized) ╔ Public Housing Authorities/Indian Housing Authorities Non-government Organizations: ╔ American Indian or Alaska native tribally designated organizations ╔ Nonprofit with 501C3 IRS status (other than institution of higher education) ╔ Nonprofit without 501C3 IRS status (other than institution of higher education) Private colleges and universities Community-based organizations Faith-based organizations For-profit organizations (other than small business) Small businesses

Funding

• Estimated Total Funding:

  $2750000

• Award Range:

  $0 - $550000

Grant Description

The purpose of this FOA is to fund a coordinating center to develop projects which will result in improved knowledge of transfusion-related complications. These projects must be specific to complications from blood transfusions, including alloimmunization, iron overload, transfusion-associated infections, and determining the utility of pre-existing datasets for analyzing information about these three areas compared to primarily collected data from study participants. The success of this approach will allow CDC to scale up monitoring of these complications to a broader population in future projects.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  (PGO) Technical Information Management Section (TIMS)
  Phone: 770-488-2700
  E-mail: pgotim@cdc.gov
  

• Agency Mailing Address:

  Technical Information Management Section (TIMS)

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  Please click on Full Announcement at the top of this page